Navigation Links
DMP for diabetes type 2: Current guidelines indicate some need for revision
Date:1/3/2012

On 3 January 2012, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 2. The aim of the report is to identify those recommendations from current guidelines of high methodological quality that may be relevant for the planned revision of the corresponding disease management programme (DMP). According to the results of the report, there is no compelling need for revision of any part of the DMP. However, IQWiG identified various aspects that could be supplemented and specified.

Evidence was documented in detail

One of the responsibilities of IQWiG specified by law (Social Code Book V) is to develop and issue recommendations for DMPs. In the commission now completed, which was awarded by the Federal Joint Committee (G-BA), IQWiG systematically searched for new guidelines, assessed their methodological quality, and extracted relevant recommendations on the diagnosis and treatment of diabetes mellitus type 2, its accompanying diseases and late complications, as well as on the cooperation of health care sectors. In addition, the Institute documented how highly the guideline authors graded the robustness of the recommendations. However, the sources of the recommendations were not examined again; this is where IQWiG's guideline appraisals and benefit assessments differ.

No contradictions between the DMP and current recommendations

A total of 35 German and international guidelines containing recommendations on the treatment of diabetes type 2 were included. As the analysis showed, the recommendations are, by and large, consistent with the specifications of the DMP. No contradictions in content concerning the DMP requirements were found. The Director of IQWiG, Professor Dr med. Jrgen Windeler, stresses that "patients with diabetes mellitus type 2 can thus be sure that the current DMP is consistent with the current status of medical knowledge on all main points."

Some potential additional recommendations identified for the DMP

However, in these guidelines, recommendations were found on a total of 8 subject areas where, after examination and discussion, the need was identified to update and supplement the German DMP for diabetes mellitus type 2, or at least to discuss such measures.

For example, some guidelines recommend additional medication. Among other things, this applies to the topical use of isosorbide dinitrate and capsaicin spray for treatment of painful diabetic neuropathy. For the prevention and treatment of diabetic foot syndrome, guidelines recommend examining the condition of the blood vessels by means of the ankle-arm index.

It is first of all the Institute's responsibility to identify differences between guideline recommendations and the DMP. The Federal Joint Committee then examines whether these differences should actually lead to a revision of the DMP for diabetes mellitus type 2.


'/>"/>
Contact: Anna-Sabine Ernst
presse@iqwig.de
49-221-356-850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Related medicine news :

1. Gestational diabetes and low socioeconomic status linked with increased risk of ADHD in offspring
2. Obesity, Diabetes Pose 1-2 Threat to Young Americans
3. Dr. Andrew Advani receives Diabetes Innovation Award
4. Holiday Travel Tips for People With Diabetes
5. Hepatitis B Vaccine Recommended for Adults With Diabetes
6. Driving Isnt An Issue for Most People With Diabetes
7. Diabetes, Obesity After 60 May Drive Up Breast Cancer Risk
8. Rotating night shift work linked to increased risk of Type 2 diabetes in women
9. Rotating Shift Work May Boost Womens Diabetes Risk
10. Vitamin D Levels Tied to Diabetes Risk in Obese Kids
11. Risk for Dementia Rises When Diabetes, Depression Meet: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... California Senate ... medical payments per workers’ compensation claim in 2013 and 2014, according to CompScope™ ... Research Institute (WCRI) . , According to the study, medical payments per claim in ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael ... headquartered in Hamilton County, is embarking on a charity drive with the aim ... new homes for orphaned or neglected senior dogs in the Cincinnati region, and ...
(Date:12/8/2016)... Fort Payne, AL (PRWEB) , ... December 08, ... ... enterprise offering insurance and financial consulting services to residential and commercial clients in ... raise awareness and support for Nobis Works. , Since 1977, Nobis Works has ...
(Date:12/7/2016)... Wisconsin (PRWEB) , ... December 07, 2016 , ... Kenall ... extraordinary new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire ... right amount of light where and when it’s needed. , A 2’ ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... (“Presence”) for a purchase price of approximately $17.4 million (net of the ... revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is a ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  A new study by a ... use of opioid therapy to treat chronic pain is ... of more harmful consequences, including death. Palliative ... Zankhana Mehta , M.D., authored the study which ... opioid therapy. The study was published in the December ...
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch die CFDA sowie ... – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during the Chinese Congress ... Union Hospital ...
Breaking Medicine Technology: